Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil bans PHD of Sao Paulo:

This article was originally published in Clinica

Executive Summary

The Brazilian healthcare surveillance agency, ANVISA, has effectively banned the Sao Paulo-based hospital and diagnostics supplies company PHD Produtos Hospitalares e Diagnosticos Ltda, following last week's market withdrawal of all its products. The measure was adopted because of a number of irregularities reported by the S-o Paulo healthcare vigilance centre, namely that the company did not have a products register and was found to have "forged the use-by dates of its products, by relabelling them", says ANVISA. PHD specialised in contrast agents and other products used in radiography and in computed tomography imaging. Distributors or retail outlets that fail to observe the ban risk a fine of up to R$1.5 million (US$611,000) and a withdrawal of their trading licence.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel